ChartRow logo
ChartRow
Investing Charts
BDX
Becton Dickinson and CompanyStock · HealthcareS&P 500 0.1%
$156.34+$3.37 (+2.20%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

BDXBecton Dickinson and Company stock price, chart and key statistics

Key stats

Price data

Price
$156.34
Change YTD
+2.01%
Next earnings
Aug 6, 2026 · Before open
Market cap
43.1B
Enterprise value
57B
Shares outstanding
275.5M
52W low
$127.59
52W high
$187.35
From 52W high
-16.55%
From 52W low
+22.54%
52W range
48%
Beta
0.27

Volume

Rel volume
0.63×
30D volume
2.4M
30D $ vol
358.6M

Fundamentals

Sales (ttm)
21.4B
Sales/share
$77.54
EPS (ttm)
$4.06
FCF (ttm)
2.7B
FCF/share
$9.69
Book value/share
$87.58
Net margin
5.33%
ROE
4.72%
ROA
2.24%
Debt / equity
0.61×
Current ratio
0.94

Growth (CAGR, ttm) · 10Y

Sales
+5.74%
Net income
+3.46%
FCF
+8.94%
Shares
+2.65%

Per-share growth (CAGR, ttm) · 10Y

EPS
+0.79%
Sales/share
+3.01%
FCF/share
+5.68%
Book value/share
+9.26%
Dividend/share
+5.65%
Price
+1.61%
Total return
+3.52%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
37.9×
Fwd P/E
11.4×
P/S (ttm)
2.0×
P/B (mrq)
1.8×
P/FCF (ttm)
16.1×
EV/EBITDA (fy)
11.3×
EV/Sales (ttm)
2.7×
FCF yield (ttm)
6.20%
Dividend yield (fwd)
2.69%
Dividend/share (fwd)
$4.20
Buyback yield (ttm)
5.80%
Shareholder yield (ttm)
8.58%

Vs own 10Y history

P/E
59th
P/S
8th
P/B
10th
P/FCF
21st

Bar = where today's multiple sits in BDX's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+2.20%
1W
-1.16%
1M
+5.80%
3M
+0.96%
YTD
+2.01%
1Y
+8.92%
5Y
-17.83%

Financial statements

Open full BDX financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B

Becton Dickinson and Company (BDX) trades at $156.34 with a live price and an interactive chart covering 53+ years of daily price history, plus key valuation metrics. ChartRow also publishes BDX's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BDX financial statements →